iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Shorted: Short Interest Down 55.2% in September

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large drop in short interest in September. As of September 15th, there was short interest totaling 23,081 shares, a drop of 55.2% from the August 31st total of 51,524 shares. Based on an average daily trading volume, of 151,159 shares, the short-interest ratio is currently 0.2 days. Currently, 0.3% of the shares of the stock are sold short.

iShares Genomics Immunology and Healthcare ETF Price Performance

NYSEARCA IDNA traded up $0.02 on Monday, hitting $41.79. The company had a trading volume of 126,035 shares, compared to its average volume of 58,850. The company has a market capitalization of $284.17 million, a PE ratio of 14.76 and a beta of 0.95. The company’s fifty day moving average price is $37.12 and its 200-day moving average price is $32.72. iShares Genomics Immunology and Healthcare ETF has a 12-month low of $22.76 and a 12-month high of $42.03.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new stake in iShares Genomics Immunology and Healthcare ETF stock. NewEdge Advisors LLC acquired a new position in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 961 shares of the company’s stock, valued at approximately $32,000.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.